Technology
Health
Biotechnology

Vermillion

$1.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.88%) Today
+$0.01 (0.88%) After Hours

Why Robinhood?

You can buy or sell Vermillion and other stocks, options, ETFs, and crypto commission-free!

About

Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Read More The company's bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion was founded on December 9, 1993 and is headquartered in Austin, TX.

Employees
43
Headquarters
Austin, Texas
Founded
1993
Market Cap
86.07M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
152.76K
High Today
$1.18
Low Today
$1.11
Open Price
$1.12
Volume
11.43K
52 Week High
$1.57
52 Week Low
$0.2701

Collections

Technology
Health
Biotechnology
Medical
US
North America
Female CEOs

News

Yahoo FinanceMay 14

Vermillion: 1Q Earnings Snapshot

AUSTIN, Texas (AP) _ Vermillion Inc. (VRML) on Tuesday reported a loss of $3.7 million in its first quarter. The Austin, Texas-based company said it had a loss of 5 cents per share. The diagnostic and bio-analytical company posted revenue of $803,000 in the period. Scroll to continue with content Ad In the final minutes of trading on Tuesday, the company's shares hit $1.34. A year ago, they were trading at $1.27. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) us...

25
Yahoo FinanceMay 14

Vermillion, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 14, 2019 / Vermillion, Inc. (NASDAQ: VRML) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 14, 2019 at 4:30 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/C-8AEE4ED6C711E To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile. Scroll to continue with con...

3
Yahoo FinanceMay 13

Vermillion Announces Acceptance of Publication Ethnic Disparity Data Showing OVA1® Superiority over CA125 and HE4 in Detecting Ovarian Cancer Risk

Data showing detection improvements across all populations, with marked improvement in detecting ovarian malignancy risk in the African American population Findings to be published in Biomarkers in Cancer AUSTIN, Texas, May 13, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced acceptance of a paper entitled: “Multivariate Index Assay is Superior to CA125 and HE4 Testing in Detection of Ovarian Malignancy in Afri...

56

Earnings

-$0.06
-$0.05
-$0.05
-$0.04
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
-$0.05 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.